Medication patterns in older adults with multimorbidity: a cluster analysis of primary care patients

BMC Fam Pract. 2019 Jun 13;20(1):82. doi: 10.1186/s12875-019-0969-9.

Abstract

Background: Older adults suffer from various chronic conditions which make them particularly vulnerable. The proper management of multiple drug use is therefore crucial. The aim of our study was to describe drug prescription and medication patterns in this population.

Methods: A cross-sectional study in Barcelona (Spain) using electronic health records from 50 primary healthcare centres. Participants were aged 65 to 94 years, presenting multimorbidity (≥2 chronic diseases), and had been prescribed at least 1 drug for 6 months or longer during 2009. We calculated the prevalence of prescribed drugs and identified medication patterns using multiple correspondence analysis and k-means clustering. Analyses were stratified by sex and age (65-79, 80-94 years).

Results: We studied 164,513 patients (66.8% women) prescribed a median of 4 drugs (interquartile range [IQR] = 3-7) in the 65-79 age-group and 6 drugs (IQR = 4-8) in the 80-94 age-group. A minimum of 45.9% of patients aged 65-79 years, and 61.8% of those aged 80-94 years, were prescribed 5 or more drugs. We identified 6 medication patterns, a non-specific one and 5 encompassing 8 anatomical groups (alimentary tract and metabolism, blood, cardiovascular, dermatological, musculo-skeletal, neurological, respiratory, and sensory organ).

Conclusions: Drug prescription is widespread among the elderly. Six medication patterns were identified, 5 of which were related to one or more anatomical group, with associations among drugs from different systems. Overall, guidelines do not accurately reflect the situation of the elderly multimorbid, new strategies for managing multiple drug uses are needed to optimize prescribing in these patients.

Keywords: Ageing; Cluster analysis; Drugs; Electronic health records; Multimorbidity; Primary health care.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Adrenergic alpha-Antagonists / therapeutic use
  • Age Factors
  • Aged
  • Aged, 80 and over
  • Anilides / therapeutic use
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Antihypertensive Agents / therapeutic use
  • Benzodiazepines / therapeutic use
  • Cluster Analysis
  • Cross-Sectional Studies
  • Female
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Hypoglycemic Agents / therapeutic use
  • Male
  • Multimorbidity
  • Multiple Chronic Conditions / drug therapy*
  • Platelet Aggregation Inhibitors / therapeutic use
  • Polypharmacy*
  • Primary Health Care*
  • Proton Pump Inhibitors / therapeutic use
  • Selective Serotonin Reuptake Inhibitors / therapeutic use
  • Sex Factors
  • Spain

Substances

  • Adrenal Cortex Hormones
  • Adrenergic alpha-Antagonists
  • Anilides
  • Anti-Inflammatory Agents, Non-Steroidal
  • Antihypertensive Agents
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Hypoglycemic Agents
  • Platelet Aggregation Inhibitors
  • Proton Pump Inhibitors
  • Serotonin Uptake Inhibitors
  • Benzodiazepines